• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

米托蒽醌、氨甲蒽醌及其类似物与DNA结合的动力学:与结合模式及抗肿瘤活性的关系。

Kinetics of the binding of mitoxantrone, ametantrone and analogues to DNA: relationship with binding mode and anti-tumour activity.

作者信息

Denny W A, Wakelin L P

机构信息

Cancer Research Laboratory, University of Auckland School of Medicine, New Zealand.

出版信息

Anticancer Drug Des. 1990 May;5(2):189-200.

PMID:2357264
Abstract

The kinetics of association and dissociation of DNA complexes of the anti-tumour agents mitoxantrone, ametantrone and related 1,4-bis(alkylamino)anthraquinones have been determined by stopped-flow spectrophotometry, in order to study relationships between structure, kinetic parameters and biological activity. Variations in the structure of the side chains of ametantrone analogues had little effect on the kinetic stability of the complexes, but the mitoxantrone complexes dissociated about an order of magnitude more slowly, suggesting an important role for the two hydroxyl groups on the chromophore of the latter compound. The results are consistent with other n.m.r. and molecular mechanics data, which suggest a binding model where the chromophore intercalates perpendicularly to the DNA base pair axis. Dissociation studies with DNA homopolymers of varying base composition suggest the kinetic mechanism is a mixed parallel/sequential one, with the slowest dissociation processes being from GC-rich sites in both homopolymers and natural DNA. The results suggest guidelines for the design of more tumour-active analogues of the class.

摘要

为了研究结构、动力学参数和生物活性之间的关系,采用停流分光光度法测定了抗肿瘤药物米托蒽醌、氨甲蒽醌及相关的1,4 - 双(烷基氨基)蒽醌的DNA复合物的缔合和解离动力学。氨甲蒽醌类似物侧链结构的变化对复合物的动力学稳定性影响很小,但米托蒽醌复合物的解离速度要慢大约一个数量级,这表明后一种化合物发色团上的两个羟基起重要作用。这些结果与其他核磁共振和分子力学数据一致,这些数据表明存在一种结合模型,即发色团垂直于DNA碱基对轴插入。对不同碱基组成的DNA均聚物的解离研究表明,动力学机制是一种混合的平行/顺序机制,在均聚物和天然DNA中,最慢的解离过程都发生在富含GC的位点。这些结果为该类更具肿瘤活性的类似物的设计提供了指导方针。

相似文献

1
Kinetics of the binding of mitoxantrone, ametantrone and analogues to DNA: relationship with binding mode and anti-tumour activity.米托蒽醌、氨甲蒽醌及其类似物与DNA结合的动力学:与结合模式及抗肿瘤活性的关系。
Anticancer Drug Des. 1990 May;5(2):189-200.
2
Peptidyl anthraquinones as potential antineoplastic drugs: synthesis, DNA binding, redox cycling, and biological activity.肽基蒽醌类作为潜在的抗肿瘤药物:合成、DNA结合、氧化还原循环及生物活性。
J Med Chem. 1996 Aug 2;39(16):3114-22. doi: 10.1021/jm950924a.
3
Sequence selectivity of topoisomerase II DNA cleavage stimulated by mitoxantrone derivatives: relationships to drug DNA binding and cellular effects.米托蒽醌衍生物刺激下拓扑异构酶II DNA切割的序列选择性:与药物DNA结合及细胞效应的关系
Mol Pharmacol. 1993 May;43(5):715-21.
4
Rational design, synthesis, and DNA binding properties of novel sequence-selective peptidyl congeners of ametantrone.新型序列选择性氨甲喋呤肽类似物的合理设计、合成与 DNA 结合性质。
ChemMedChem. 2010 Jul 5;5(7):1080-91. doi: 10.1002/cmdc.201000106.
5
Spectrofluorometric studies on the binding of the antitumor drugs ametantrone and mitoxantrone to bovine serum albumin.抗肿瘤药物氨甲蒽醌和米托蒽醌与牛血清白蛋白结合的荧光光谱研究。
Biomed Biochim Acta. 1990;49(10):1091-6.
6
Stopped-flow kinetic analysis of the interaction of anthraquinone anticancer drugs with calf thymus DNA, poly[d(G-C)].poly[d(G-C)], and poly[d(A-T)].poly[d(A-T)].蒽醌类抗癌药物与小牛胸腺DNA、聚[d(G-C)]·聚[d(G-C)]以及聚[d(A-T)]·聚[d(A-T)]相互作用的停流动力学分析
Biochemistry. 1986 Oct 7;25(20):5933-40. doi: 10.1021/bi00368a015.
7
Mitoxantrone and ametantrone induce interstrand cross-links in DNA of tumour cells.米托蒽醌和氨甲蒽醌可诱导肿瘤细胞DNA中的链间交联。
Br J Cancer. 2000 Apr;82(7):1300-4. doi: 10.1054/bjoc.1999.1095.
8
Kinetic and equilibrium studies of the interaction of amsacrine and anilino ring-substituted analogues with DNA.
Cancer Res. 1986 Apr;46(4 Pt 1):1717-21.
9
DNA recognition by two mitoxantrone analogues: influence of the hydroxyl groups.
FEBS Lett. 1996 Feb 5;379(3):269-72. doi: 10.1016/0014-5793(95)01528-0.
10
The geometry of intercalation complex of antitumor mitoxantrone and ametantrone with DNA: molecular dynamics simulations.抗肿瘤药米托蒽醌和氨甲蒽醌与DNA嵌入复合物的几何结构:分子动力学模拟
Acta Biochim Pol. 1998;45(1):1-11.

引用本文的文献

1
GSH/pH-Responsive Chitosan-PLA Hybrid Nanosystems for Targeted Ledipasvir Delivery to HepG2 Cells: Controlled Release, Improved Selectivity, DNA Interaction, Electrochemical and Stopped-Flow Kinetics Analyses.用于将雷迪帕韦靶向递送至HepG2细胞的谷胱甘肽/ pH响应型壳聚糖-聚乳酸混合纳米系统:控释、选择性提高、DNA相互作用、电化学和停流动力学分析
Int J Mol Sci. 2025 Jun 24;26(13):6070. doi: 10.3390/ijms26136070.
2
Pixantrone Sensitizes Gram-Negative Pathogens to Rifampin.比沙可啶使革兰氏阴性病原体对利福平敏感。
Microbiol Spectr. 2022 Dec 21;10(6):e0211422. doi: 10.1128/spectrum.02114-22. Epub 2022 Nov 1.
3
Synthesis, docking and biological activities of novel hybrids celecoxib and anthraquinone analogs as potent cytotoxic agents.
新型杂合物塞来昔布与蒽醌类似物作为强效细胞毒性剂的合成、对接及生物活性
Int J Mol Sci. 2014 Dec 5;15(12):22580-603. doi: 10.3390/ijms151222580.
4
Initial testing (stage 1) of the topoisomerase II inhibitor pixantrone, by the pediatric preclinical testing program.儿科临床前试验计划对拓扑异构酶 II 抑制剂比沙酮进行初步测试(第 1 阶段)。
Pediatr Blood Cancer. 2014 May;61(5):922-4. doi: 10.1002/pbc.24800. Epub 2013 Oct 26.
5
Can anthracycline therapy for pediatric malignancies be less cardiotoxic?儿科恶性肿瘤的蒽环类药物治疗能否减少心脏毒性?
Curr Oncol Rep. 2010 Nov;12(6):411-9. doi: 10.1007/s11912-010-0129-9.
6
Rationale for the use of aliphatic N-oxides of cytotoxic anthraquinones as prodrug DNA binding agents: a new class of bioreductive agent.将细胞毒性蒽醌类脂肪族氮氧化物用作前药DNA结合剂的原理:一类新型生物还原剂。
Cancer Metastasis Rev. 1993 Jun;12(2):119-34. doi: 10.1007/BF00689805.
7
AQ4N: an alkylaminoanthraquinone N-oxide showing bioreductive potential and positive interaction with radiation in vivo.AQ4N:一种具有生物还原潜力且在体内与辐射有正向相互作用的烷基氨基蒽醌氮氧化物。
Br J Cancer. 1995 Jul;72(1):76-81. doi: 10.1038/bjc.1995.280.